Wells Fargo
DRTS icon

Wells Fargo’s Alpha Tau Medical DRTS Stock Holding History

Wells Fargo’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$349K Buy
49,300
+25,800
+110% +$182K ﹤0.01% 4343
2025
Q4 		$116K Buy
23,500
+17,500
+292% +$73.8K ﹤0.01% 5322
2025
Q3 		$27.1K Buy
6,000
+3,500
+140% +$11.9K ﹤0.01% 5720
2025
Q2 		$7.8K Buy
+2,500
New +$7.04K ﹤0.01% 6010
2024
Q2 		– Sell
-10,556
Closed -$31.1K – 7038
2024
Q1 		$31.1K Sell
10,556
-250
-2% -$768 ﹤0.01% 5435
2023
Q4 		$32.5K Hold
10,806
– – ﹤0.01% 5442
2023
Q3 		$41K Hold
10,806
– – ﹤0.01% 5282
2023
Q2 		$47.2K Hold
10,806
– – ﹤0.01% 5454
2023
Q1 		$31K Hold
10,806
– – ﹤0.01% 5433
2022
Q4 		$34.4K Hold
10,806
– – ﹤0.01% 5029
2022
Q3 		$63K Buy
+10,806
New +$95.3K ﹤0.01% 4836

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Wells Fargo's DRTS Position: Q1 2026 in Review

Wells Fargo increased its Alpha Tau Medical (DRTS) stake by 110% in Q1 2026, buying an estimated $182K and bringing the position to 49,300 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

Wells Fargo first reported a position in DRTS in Q3 2022 and has held it in 11 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Wells Fargo held 49,300 shares of Alpha Tau Medical worth $349K as of Q1 2026.
  • Wells Fargo bought 25,800 Alpha Tau Medical shares in Q1 2026, an estimated $182K.
  • Alpha Tau Medical made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4343 holding.
  • Wells Fargo first reported a position in Alpha Tau Medical in Q3 2022 and has held it in 11 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.